These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15892088)

  • 1. Optimizing peripheral stem cell mobilization and harvest in very small children.
    Strahlendorf C
    J Clin Apher; 2005 Jul; 20(2):63-4. PubMed ID: 15892088
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rapid determination of optimal time for peripheral blood stem cell harvest by detecting hematopoietor progenitor cell during mobilization].
    Guo JJ; Wu SY; Chen YL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):570-3. PubMed ID: 16320591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the haematopoietic progenitor cell parameter in optimizing timing of peripheral blood stem cell harvest.
    Padmanabhan A; Reich-Slotky R; Jhang JS; Dael S; Crowder T; Colovai AI; Schwartz J
    Vox Sang; 2009 Aug; 97(2):153-9. PubMed ID: 19392781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen.
    Dawson MA; Schwarer AP; Muirhead JL; Bailey MJ; Bollard GM; Spencer A
    Bone Marrow Transplant; 2005 Sep; 36(5):389-96. PubMed ID: 15980882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex.
    Zhang C; Chen X; Zhang X; Gao L; Kong P; Wang Q; Peng X; Liu H
    Transfus Apher Sci; 2008 Aug; 39(1):21-8. PubMed ID: 18599353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma.
    Schroeder H; Kamperis K; Grunnet N; Hokland P
    Pediatr Blood Cancer; 2006 Jun; 46(7):786-92. PubMed ID: 16333829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers.
    Goterris R; Hernández-Boluda JC; Teruel A; Gómez C; Lis MJ; Terol MJ; Tormo M; Solano C; Arbona C
    Bone Marrow Transplant; 2005 Nov; 36(10):847-53. PubMed ID: 16113660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous peripheral blood stem cell collections in children weighing less than 10 Kg with solid tumors: experience of a single center.
    Cho HJ; Jung HK; Sung KW; Ku HH; Lee SH; Kim DW
    J Clin Apher; 2005 Jul; 20(2):65-71. PubMed ID: 15892091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of experimental murine models to assess novel agents of hematopoietic stem and progenitor cell mobilization.
    Herbert KE; Lévesque JP; Haylock DN; Prince HM
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):603-21. PubMed ID: 18489986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
    Bruns I; Steidl U; Kronenwett R; Fenk R; Graef T; Rohr UP; Neumann F; Fischer J; Scheid C; Hübel K; Haas R; Kobbe G
    Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
    Fruehauf S; Klaus J; Huesing J; Veldwijk MR; Buss EC; Topaly J; Seeger T; Zeller LW; Moehler T; Ho AD; Goldschmidt H
    Bone Marrow Transplant; 2007 Jun; 39(12):743-50. PubMed ID: 17450182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving stem cell mobilization strategies: future directions.
    Bensinger W; DiPersio JF; McCarty JM
    Bone Marrow Transplant; 2009 Feb; 43(3):181-95. PubMed ID: 19139734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of viable CD34+ cells from cryopreserved hemopoietic progenitor cell products.
    Sartor M; Antonenas V; Garvin F; Webb M; Bradstock KF
    Bone Marrow Transplant; 2005 Aug; 36(3):199-204. PubMed ID: 15937512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomised comparison of the COBE spectra version 6 and haemonetics MCS(+) cell separators for hematopoietic progenitor cells leucapheresis in patients with multiple myeloma.
    Abdelkefi A; Maamar M; Torjman L; Ladeb S; Lakhal A; Ben Othman T; Slama H; Jenhani F; Mojaat N; Ben Hamed L; Bouhoula S; Hsairi M; Boukef K; Ben Abdeladhim A
    J Clin Apher; 2006 Jul; 21(2):111-5. PubMed ID: 16395725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.
    Abraham M; Biyder K; Begin M; Wald H; Weiss ID; Galun E; Nagler A; Peled A
    Stem Cells; 2007 Sep; 25(9):2158-66. PubMed ID: 17525235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 4-integrin-positive microvesicles and SDF-1 in peripheral blood stem cell harvest.
    Nomura S; Ishii K; Inami N; Kimura Y; Uoshima N; Urase F; Maeda Y; Hayshi K
    Bone Marrow Transplant; 2008 Jun; 41(12):1071-2. PubMed ID: 18332911
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings.
    Wang TF; Wen SH; Chen RL; Lu CJ; Zheng YJ; Yang SH; Chu SC; Kao RH; Chen SH
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1305-11. PubMed ID: 18940686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.